Source: Eur Respir J 2016; 48: 451-458
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dekkers Johanna F., Gogorza Gondra Ricardo A., Kruisselbrink Evelien, Vonk Annelotte M., Janssens Hettie M., de Winter-de Groot Karin M., van der Ent Cornelis K., Beekman Jeffrey M.. Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids. Eur Respir J 2016; 48: 451-458

Member's Comments

No comment yet.

Related content which might interest you: Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019 Year: 2021 Potentiating and correcting mutant CFTR in patients with cystic fibrosis Source: Eur Respir Monogr 2014; 64: 129-149 Year: 2014 Individual treatment of cystic fibrosis by using intestinal organoids Source: International Congress 2015 – Advancing therapies for cystic fibrosis Year: 2015 Measuring CFTR function in respiratory epithelial cell cultures: step to individualize treatments in cystic fibrosis? Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Correcting the basic ion transport defects in cystic fibrosis Source: Eur Respir Monogr 2014; 64: 116-128 Year: 2014 Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021 Year: 2022 Targeting CFTR as a therapy for cystic fibrosis Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 CFTR: cystic fibrosis and beyond Source: Eur Respir J 2014; 44: 1042-1054 Year: 2014 Intestinal organoids to model cystic fibrosis Source: Eur Respir J, 54 (1) 1802379; 10.1183/13993003.02379-2018 Year: 2019 Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient Source: Eur Respir J 2002; 19: 374-376 Year: 2002 Is mitochondria morphology altered in epithelial cells with cystic fibrosis? Source: Eur Respir J 2003; 22: Suppl. 45, 501s Year: 2003 Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue Source: Eur Respir J 2012; 40: 1390-1400 Year: 2012 Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006 Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Source: Eur Respir Rev 2013; 22: 58-65 Year: 2013 The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model Source: Eur Respir J, 52 (6) 1801133; 10.1183/13993003.01133-2018 Year: 2018 Peptide transport mechanisms in cystic fibrosis and normal human lung Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001 Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006 Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients Source: Eur Respir J 2004; 23: 679-684 Year: 2004 How organoids helped to discover cystic fibrosis transmembrane conductance regulator (CFTR) therapeutics and predict response to treatment Source: International Congress 2016 – Closing the gap: novel translational research strategies Year: 2016